A.Vogel
A.Vogel
A.Vogel A.Vogel
A.Vogel
A.Vogel
A.Vogel
A.Vogel
View from Alfred Vogel's Clinic at Teufen A.Vogel

A.Vogel
A.Vogel
Echinaforce® in the Treatment of Colds and Flu

A recently published review of Echinacea trials by the authoritative Cochrane Library gives some very positive news for Echinacea purpurea, the herb variety used in Echinaforce (1).


This latest research confirms that Echinaforce is an effective treatment for colds and flu.


The key findings are:

There IS EVIDENCE that Echinacea purpurea is effective in the early treatment of colds
Echinacea preparations differ greatly in quality and effectiveness
Products using Echinacea purpurea based on the aerial parts of the plant are more likely to be effective.
Beneficial effects of other Echinacea preparations or products may exist, but have not been proven in independent, rigorous trials.

Echinaforce®

 Produced from Echinacea purpurea herb (95%) and root (5%)

 Grown organically to Good Agricultural Practice (GAP)
standards

Manufactured to the highest Good Manufacturing Practice (GMP) standards

Backed by a considerable body of research proving its effectiveness (2-4).


Made by Nature, Proven by Science, Used by Millions all over the World.

For more information, contact our helpline on 0845 608 5858.

References
(1) Linde K, Barrett B, Wölkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold (Review). The Cochrane Database of Systematic
Reviews 2006, Issue 1. Art. No.: CD000530.pub2. DOI:10.1002/14651858.CD000530.pub2.
http://www.cochrane.org/reviews/en/ab000530.html
(2) Dengenring FH. Studies on the therapeutic effi cacy of Echinaforce. GanzheitsMedizine 1995;2/95:88-94.
(3) Brinkeborn RM, Shah DV, Degenring FH. Echinaforce and other Echincaea fresh plant preparations in the treatment of the common cold. A randomized,
placebo-controlled, double-blind clinical trial. Phytomedicine 1999;6:1-5.
(4) Gersch J, et al. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways.
FEBS Letters 2004; 577:563-569.

1 February 2006

A.Vogel A.Vogel A.Vogel
Send to a friend